Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Creso Pharma Limited
  6. News
  7. Summary
    CPH   AU000000CPH2

CRESO PHARMA LIMITED

(CPH)
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Creso Pharma : Canadian Subsidiary Conducts Stability Testing for Upcoming Phase 2 Clinical Trial

10/06/2021 | 04:44am EST


ę MT Newswires 2021
All news about CRESO PHARMA LIMITED
12/01Creso Pharma's Psychedelics Unit Secures Upgraded Dealer's License in Canada; Shares Up..
MT
11/17CRESO PHARMA : Application for quotation of securities - CPH
PU
11/17CRESO PHARMA : Notification of cessation of securities - CPH
PU
11/14Creso Pharma Completes Integration of ImpACTIVE Assets
CI
11/03Creso Pharma Limited Appoints Brian Walker MLC as Strategic Consultant and Chair to New..
CI
10/31Creso Pharma Enters Deal to Sell Medicinal Cannabis in Switzerland; Shares Jump 8%
MT
10/31Creso Pharma Limited Secures Non-Binding Letter of Intent with Licensed Cannabis Grower..
CI
10/31Creso Pharma Limited to Enter Swiss Medicinal Cannabis Market
CI
10/25CRESO PHARMA : Acquires Canadian Life Sciences Company's Assets to Strengthen North Americ..
MT
10/25Creso Pharma Limited completed the acquisition of Brand and Product Portfolio Assets of..
CI
More news
Financials
Sales 2020 2,45 M 1,74 M 1,74 M
Net income 2020 -30,8 M -21,9 M -21,9 M
Net cash 2020 2,79 M 1,98 M 1,98 M
P/E ratio 2020 -2,17x
Yield 2020 -
Capitalization 109 M 76,6 M 77,2 M
EV / Sales 2019 6,12x
EV / Sales 2020 65,2x
Nbr of Employees -
Free-Float 88,0%
Chart CRESO PHARMA LIMITED
Duration : Period :
Creso Pharma Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CRESO PHARMA LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
Chris Grundy Chief Financial Officer
James Anthony Ellingford Chairman
Carole Abel Director-Commercial Operations
Boaz Wachtel Non-Executive Director
Erlyn Dale Joint Secretary
Sector and Competitors
1st jan.Capi. (M$)
CRESO PHARMA LIMITED-50.00%77
JOHNSON & JOHNSON3.53%428 955
ROCHE HOLDING AG17.23%322 390
PFIZER, INC.44.09%288 950
NOVO NORDISK A/S65.08%245 091
ELI LILLY AND COMPANY45.45%223 321